New drug clinical trial initiation time reduction
RecordSTO-C77BGGGW97-RJ6S1EQC0E-H52WY1
China · 2025
New drug clinical trial initiation time reduction in China was 4 months in 2025 (NHSA).
New drug clinical trial initiation time reduction: every country and year, and how it is measured
- Publisher
- NHSA
- Authority tier
- T1 Official
- Locator
- 试验包括新药临床试验和生物等效性试验
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
报告显示，2025年我国签署首例受试者知情同意书的新药临床试验1088项，平均启动用时同比缩短4个月。
Checked: the figure 4 monthsis stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Healthcare Security Administration. (2025). 从“0”到“1”创新能力增强 我国新药研发热度持续攀升. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Via StatOrigin, https://statorigin.org/stat/stat_C77BGGGW97RJ6S1EQC0EH52WY1
Other formats: MLA, Chicago, BibTeX
- MLA
- National Healthcare Security Administration. "从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025, http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_C77BGGGW97RJ6S1EQC0EH52WY1.
- Chicago
- National Healthcare Security Administration. "从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025. http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_C77BGGGW97RJ6S1EQC0EH52WY1.
- BibTeX
- @misc{nhsa2025drugh52wy1, author = {{National Healthcare Security Administration}}, title = {从“0”到“1”创新能力增强 我国新药研发热度持续攀升}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_C77BGGGW97RJ6S1EQC0EH52WY1}, note = {Original source: http://www.nhsa.gov.cn/art/2026/6/23/art\_14\_21076.html. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Healthcare Security Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 从“0”到“1”创新能力增强 我国新药研发热度持续攀升
- Type
- Press release
- Published
- —
- Locator
- 试验包括新药临床试验和生物等效性试验
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_C77BGGGW97RJ6S1EQC0EH52WY1